{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T00:35:04Z","timestamp":1793579704081,"version":"4.5.0"},"reference-count":175,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["HT94252310443"],"award-info":[{"award-number":["HT94252310443"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000952","name":"Paul G Allen Family Foundation","doi-asserted-by":"publisher","award":["19PABH134580006"],"award-info":[{"award-number":["19PABH134580006"]}],"id":[{"id":"10.13039\/100000952","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008796","name":"Allen Foundation","doi-asserted-by":"publisher","award":["R01AG071512"],"award-info":[{"award-number":["R01AG071512"]}],"id":[{"id":"10.13039\/100008796","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS133688"],"award-info":[{"award-number":["R01NS133688"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG077396"],"award-info":[{"award-number":["RF1AG077396"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009382","name":"Solve ME CFS Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS133688"],"award-info":[{"award-number":["R01NS133688"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.neurot.2025.e00627","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T23:38:51Z","timestamp":1750462731000},"page":"e00627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Intersection of H2S and Nrf2 signaling: Therapeutic opportunities for neurodegenerative diseases"],"prefix":"10.1016","volume":"22","author":[{"given":"Priyanka","family":"Soni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shravan","family":"Paswan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bindu D.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobby","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neurot.2025.e00627_bib1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cell.2017.06.036","article-title":"Evolution of the human nervous system function, structure, and development","volume":"170","author":"Sousa","year":"2017","journal-title":"Cell."},{"issue":"3","key":"10.1016\/j.neurot.2025.e00627_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031851","article-title":"A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics","volume":"23","author":"Lamptey","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2025.e00627_bib3","doi-asserted-by":"crossref","DOI":"10.14336\/AD.2024.1071","article-title":"The expanding burden of neurodegenerative diseases: an unmet medical and social need","author":"Wang","year":"2024","journal-title":"Aging Dis"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00627_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12939-024-02212-5","article-title":"Global, regional, and national health inequalities of Alzheimer's disease and Parkinson's disease in 204 countries, 1990-2019","volume":"23","author":"Ji","year":"2024","journal-title":"Int J Equity Health"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00627_bib5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1474-4422(19)30411-9","article-title":"The global burden of neurological disorders: translating evidence into policy","volume":"19","author":"Feigin","year":"2020","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00627_bib6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"issue":"21","key":"10.1016\/j.neurot.2025.e00627_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112854","article-title":"Neurodegenerative diseases: from molecular basis to therapy","volume":"23","author":"Agnello","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00627_bib8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1582-4934.2010.01010.x","article-title":"Basic mechanisms of neurodegeneration: a critical update","volume":"14","author":"Jellinger","year":"2010","journal-title":"J Cell Mol Med"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00627_bib9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurot.2025.e00627_bib10","series-title":"Brain aging: models, methods, and mechanisms","article-title":"Oxidative stress and the aging brain: from theory to prevention","author":"Gemma","year":"2007"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00627_bib11","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1089\/ars.2017.7321","article-title":"Redox mechanisms in neurodegeneration: from disease outcomes to therapeutic opportunities","volume":"30","author":"Sbodio","year":"2019","journal-title":"Antioxid Redox Signal"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00627_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23115938","article-title":"An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases","volume":"23","author":"Teleanu","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00627_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24081583","article-title":"Oxidative stress: a key modulator in neurodegenerative diseases","volume":"24","author":"Singh","year":"2019","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00627_bib14","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028035","article-title":"Pathology of neurodegenerative diseases","volume":"9","author":"Dugger","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.neurot.2025.e00627_bib15","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","article-title":"Oxidative stress","volume":"86","author":"Sies","year":"2017","journal-title":"Annu Rev Biochem"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00627_bib16","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41580-024-00730-2","article-title":"Fundamentals of redox regulation in biology","volume":"25","author":"Sies","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00627_bib17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12325-019-01148-5","article-title":"Pathophysiology and therapeutic perspectives of oxidative stress and neurodegenerative diseases: a narrative review","volume":"37","author":"Rekatsina","year":"2020","journal-title":"Adv Ther"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00627_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad356","article-title":"Role of oxidative stress in neurodegenerative disorders: a review of reactive oxygen species and prevention by antioxidants","volume":"6","author":"Houldsworth","year":"2024","journal-title":"Brain Commun"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00627_bib19","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1007\/s12035-015-9337-5","article-title":"Oxidative stress in neurodegenerative diseases","volume":"53","author":"Niedzielska","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.neurot.2025.e00627_bib20","doi-asserted-by":"crossref","DOI":"10.1177\/1759091419899782","article-title":"NRF2 as a therapeutic target in neurodegenerative diseases","volume":"12","author":"Brandes","year":"2020","journal-title":"ASN Neuro"},{"key":"10.1016\/j.neurot.2025.e00627_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.673205","article-title":"Challenges and limitations of targeting the keap1-nrf2 pathway for neurotherapeutics: bach1 De-repression to the rescue","volume":"13","author":"Hushpulian","year":"2021","journal-title":"Front Aging Neurosci"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00627_bib22","article-title":"Harnessing the therapeutic potential of the nrf2\/bach1 signaling pathway in Parkinson's disease","volume":"11","author":"Ahuja","year":"2022","journal-title":"Antioxidants (Basel)"},{"issue":"13","key":"10.1016\/j.neurot.2025.e00627_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00099-20","article-title":"The molecular mechanisms regulating the KEAP1-NRF2 pathway","volume":"40","author":"Baird","year":"2020","journal-title":"Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00627_bib24","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.celrep.2019.06.047","article-title":"Molecular mechanism of cellular oxidative stress sensing by Keap1","volume":"28","author":"Suzuki","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.neurot.2025.e00627_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6635460","article-title":"The keap1-nrf2 system: a mediator between oxidative stress and aging","volume":"2021","author":"Yu","year":"2021","journal-title":"Oxid Med Cell Longev"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00627_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122772","article-title":"Nrf2, the master regulator of anti-oxidative responses","volume":"18","author":"Vomund","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00627_bib27","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/alz.12694","article-title":"Global estimates on the number of persons across the Alzheimer's disease continuum","volume":"19","author":"Gustavsson","year":"2023","journal-title":"Alzheimer's Dement"},{"issue":"s1","key":"10.1016\/j.neurot.2025.e00627_bib28","doi-asserted-by":"crossref","first-page":"S611","DOI":"10.3233\/JAD-179935","article-title":"Role of amyloid-beta and tau proteins in alzheimer's disease: confuting the amyloid cascade","volume":"64","author":"Gulisano","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00627_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40035-025-00479-4","article-title":"Dual modulation of amyloid beta and tau aggregation and dissociation in Alzheimer's disease: a comprehensive review of the characteristics and therapeutic strategies","volume":"14","author":"Nam","year":"2025","journal-title":"Transl Neurodegener"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00627_bib30","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s11033-024-09771-4","article-title":"Regulation of Keap1-Nrf2 signaling in health and diseases","volume":"51","author":"Xiao","year":"2024","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.neurot.2025.e00627_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101756","article-title":"Role of Nrf2 in aging, Alzheimer's and other neurodegenerative diseases","volume":"82","author":"George","year":"2022","journal-title":"Ageing Res Rev"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00627_bib32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13195-019-0578-9","article-title":"Nrf2 activation through the PI3K\/GSK-3 axis protects neuronal cells from Abeta-mediated oxidative and metabolic damage","volume":"12","author":"Sotolongo","year":"2020","journal-title":"Alzheimers Res Ther"},{"issue":"s1","key":"10.1016\/j.neurot.2025.e00627_bib33","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.3233\/JPD-181474","article-title":"The emerging evidence of the Parkinson pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.neurot.2025.e00627_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.neurot.2025.e00627_bib35","article-title":"Role of Nrf2 in Parkinson's disease: toward new perspectives","volume":"13","author":"Yang","year":"2022","journal-title":"Front Pharmacol"},{"issue":"19","key":"10.1016\/j.neurot.2025.e00627_bib36","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1111\/febs.14607","article-title":"Determinants of dopaminergic neuron loss in Parkinson's disease","volume":"285","author":"Surmeier","year":"2018","journal-title":"FEBS J"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00627_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107742","article-title":"Alpha-synuclein, autophagy-lysosomal pathway, and Lewy bodies: mutations, propagation, aggregation, and the formation of inclusions","volume":"300","author":"Bayati","year":"2024","journal-title":"J Biol Chem"},{"issue":"17","key":"10.1016\/j.neurot.2025.e00627_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179592","article-title":"An overview of the Nrf2\/ARE pathway and its role in neurodegenerative diseases","volume":"22","author":"Zgorzynska","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00627_bib39","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.neurot.2025.e00627_bib40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/978-3-642-45106-5_14","article-title":"Huntington's disease","volume":"220","author":"Zuccato","year":"2014","journal-title":"Handb Exp Pharmacol"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00627_bib41","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41582-020-0389-4","article-title":"Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities","volume":"16","author":"Tabrizi","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurot.2025.e00627_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"7498","key":"10.1016\/j.neurot.2025.e00627_bib43","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature13136","article-title":"Cystathionine gamma-lyase deficiency mediates neurodegeneration in Huntington's disease","volume":"509","author":"Paul","year":"2014","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00627_bib44","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.cmet.2019.10.007","article-title":"Selective persulfide detection reveals evolutionarily conserved antiaging effects of S-sulfhydration","volume":"30","author":"Zivanovic","year":"2019","journal-title":"Cell Metab"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00627_bib45","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1073\/pnas.1717877115","article-title":"Golgi stress response reprograms cysteine metabolism to confer cytoprotection in Huntington's disease","volume":"115","author":"Sbodio","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"10.1016\/j.neurot.2025.e00627_bib46","doi-asserted-by":"crossref","first-page":"E4676","DOI":"10.1073\/pnas.1614943114","article-title":"KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington's disease patients","volume":"114","author":"Quinti","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00627_bib47","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/hmg\/ddx394","article-title":"HACE1 is essential for astrocyte mitochondrial function and influences Huntington disease phenotypes in vivo","volume":"27","author":"Ehrnhoefer","year":"2018","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00627_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057932","article-title":"Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin","volume":"8","author":"Jin","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00627_bib49","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.freeradbiomed.2008.05.014","article-title":"Proteomic and oxidative stress analysis in human brain samples of Huntington disease","volume":"45","author":"Sorolla","year":"2008","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00627_bib50","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1073\/pnas.1314421111","article-title":"HACE1 reduces oxidative stress and mutant Huntingtin toxicity by promoting the NRF2 response","volume":"111","author":"Rotblat","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00627_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016172","article-title":"Efficacy of fumaric acid esters in the R6\/2 and YAC128 models of Huntington's disease","volume":"6","author":"Ellrichmann","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00627_bib52","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.freeradbiomed.2010.03.017","article-title":"Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease","volume":"49","author":"Stack","year":"2010","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00627_bib53","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1523\/JNEUROSCI.16-03-01066.1996","article-title":"The possible role of hydrogen sulfide as an endogenous neuromodulator","volume":"16","author":"Abe","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurot.2025.e00627_bib54","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4627308","article-title":"Gasotransmitters in biology and medicine: molecular mechanisms and drug targets","volume":"2016","author":"Yang","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.neurot.2025.e00627_bib55","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9176923","article-title":"Synaptic secretion and beyond: targeting synapse and neurotransmitters to treat neurodegenerative diseases","volume":"2022","author":"Wei","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.neurot.2025.e00627_bib56","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1146\/annurev.neuro.26.041002.131047","article-title":"Novel neural modulators","volume":"26","author":"Boehning","year":"2003","journal-title":"Annu Rev Neurosci"},{"issue":"68","key":"10.1016\/j.neurot.2025.e00627_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.268re2","article-title":"Signaling by gasotransmitters","volume":"2","author":"Mustafa","year":"2009","journal-title":"Sci Signal"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00627_bib58","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.tibs.2014.03.003","article-title":"Gasotransmitters: growing pains and joys","volume":"39","author":"Wang","year":"2014","journal-title":"Trends Biochem Sci"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00627_bib59","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0031-6997(25)06663-3","article-title":"Nitric oxide: physiology, pathophysiology, and pharmacology","volume":"43","author":"Moncada","year":"1991","journal-title":"Pharmacol Rev"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00627_bib60","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1124\/pr.57.4.3","article-title":"Carbon monoxide: endogenous production, physiological functions, and pharmacological applications","volume":"57","author":"Wu","year":"2005","journal-title":"Pharmacol Rev"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00627_bib61","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s42255-025-01225-w","article-title":"Regulation of mammalian cellular metabolism by endogenous cyanide production","volume":"7","author":"Zuhra","year":"2025","journal-title":"Nat Metab"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00627_bib62","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrm3391","article-title":"H(2)S signalling through protein sulfhydration and beyond","volume":"13","author":"Paul","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00627_bib63","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/ars.2008.2132","article-title":"A source of hydrogen sulfide and a mechanism of its release in the brain","volume":"11","author":"Ishigami","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.neurot.2025.e00627_bib64","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.freeradbiomed.2013.02.024","article-title":"Microbial regulation of host hydrogen sulfide bioavailability and metabolism","volume":"60","author":"Shen","year":"2013","journal-title":"Free Radic Biol Med"},{"issue":"11-12","key":"10.1016\/j.neurot.2025.e00627_bib65","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1016\/j.freeradbiomed.2012.04.007","article-title":"Analytical measurement of discrete hydrogen sulfide pools in biological specimens","volume":"52","author":"Shen","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.neurot.2025.e00627_bib66","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s42003-019-0431-5","article-title":"Non-enzymatic hydrogen sulfide production from cysteine in blood is catalyzed by iron and vitamin B(6)","volume":"2","author":"Yang","year":"2019","journal-title":"Commun Biol"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00627_bib67","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1089\/ars.2017.7096","article-title":"Beyond a gasotransmitter: hydrogen sulfide and polysulfide in cardiovascular health and immune response","volume":"27","author":"Yuan","year":"2017","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00627_bib68","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/ATVBAHA.120.314084","article-title":"Reactive sulfur species: a new redox player in cardiovascular pathophysiology","volume":"40","author":"Kolluru","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.neurot.2025.e00627_bib69","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-3-319-18144-8_3","article-title":"Physiological roles of hydrogen sulfide and polysulfides","volume":"230","author":"Kimura","year":"2015","journal-title":"Handb Exp Pharmacol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00627_bib70","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/ars.2014.5917","article-title":"Modes of physiologic H2S signaling in the brain and peripheral tissues","volume":"22","author":"Paul","year":"2015","journal-title":"Antioxid Redox Signal"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00627_bib71","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1021\/acs.inorgchem.8b02592","article-title":"Saying NO to H(2)S: a story of HNO, HSNO, and SSNO","volume":"58","author":"Ivanovic-Burmazovic","year":"2019","journal-title":"Inorg Chem"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00627_bib72","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1021\/acs.chemrev.7b00205","article-title":"Chemical biology of H(2)S signaling through persulfidation","volume":"118","author":"Filipovic","year":"2018","journal-title":"Chem Rev"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00627_bib73","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nchembio.1834","article-title":"Biogenesis of reactive sulfur species for signaling by hydrogen sulfide oxidation pathways","volume":"11","author":"Mishanina","year":"2015","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.neurot.2025.e00627_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102949","article-title":"Hypoxia increases persulfide and polysulfide formation by AMP kinase dependent cystathionine gamma lyase phosphorylation","volume":"68","author":"Alam","year":"2023","journal-title":"Redox Biol"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00627_bib75","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1096\/fj.04-1815fje","article-title":"Hydrogen sulfide protects neurons from oxidative stress","volume":"18","author":"Kimura","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.neurot.2025.e00627_bib76","first-page":"1","article-title":"Hydrogen sulfide signalling in neurodegenerative diseases","author":"Tripathi","year":"2023","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00627_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101772","article-title":"Effects of hydrogen sulfide on mitochondrial function and cellular bioenergetics","volume":"38","author":"Paul","year":"2021","journal-title":"Redox Biol"},{"issue":"1-3","key":"10.1016\/j.neurot.2025.e00627_bib78","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/ars.2023.0352","article-title":"Emerging chemical biology of protein persulfidation","volume":"39","author":"Vignane","year":"2023","journal-title":"Antioxid Redox Signal"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00627_bib79","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.tibs.2015.08.007","article-title":"H2S: a novel gasotransmitter that signals by sulfhydration","volume":"40","author":"Paul","year":"2015","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.neurot.2025.e00627_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.674135","article-title":"The role of protein persulfidation in brain aging and neurodegeneration","volume":"13","author":"Petrovic","year":"2021","journal-title":"Front Aging Neurosci"},{"issue":"96","key":"10.1016\/j.neurot.2025.e00627_bib81","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2000464","article-title":"H2S signals through protein S-sulfhydration","volume":"2","author":"Mustafa","year":"2009","journal-title":"Sci Signal"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00627_bib82","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.molcel.2011.10.021","article-title":"Hydrogen sulfide-linked sulfhydration of NF-kappaB mediates its antiapoptotic actions","volume":"45","author":"Sen","year":"2012","journal-title":"Mol Cell"},{"key":"10.1016\/j.neurot.2025.e00627_bib83","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1038\/ncomms2623","article-title":"Sulfhydration mediates neuroprotective actions of parkin","volume":"4","author":"Vandiver","year":"2013","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00627_bib84","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2017225118","article-title":"Hydrogen sulfide is neuroprotective in Alzheimer's disease by sulfhydrating GSK3beta and inhibiting Tau hyperphosphorylation","volume":"118","author":"Giovinazzo","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00627_bib85","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00726-010-0510-x","article-title":"Hydrogen sulfide: its production, release and functions","volume":"41","author":"Kimura","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.neurot.2025.e00627_bib86","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fnins.2018.00214","article-title":"Oxytosis\/Ferroptosis-(Re-) emerging roles for oxidative stress-dependent non-apoptotic cell death in diseases of the central nervous system","volume":"12","author":"Lewerenz","year":"2018","journal-title":"Front Neurosci"},{"key":"10.1016\/j.neurot.2025.e00627_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.589042","article-title":"Mechanism of ferroptosis and its relationships with other types of programmed cell death: insights for potential interventions after intracerebral hemorrhage","volume":"14","author":"Zhou","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1016\/j.neurot.2025.e00627_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1390798","article-title":"A critical appraisal of ferroptosis in Alzheimer's and Parkinson's disease: new insights into emerging mechanisms and therapeutic targets","volume":"15","author":"Soni","year":"2024","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00627_bib89","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00204-023-03660-8","article-title":"Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases","volume":"98","author":"Xiang","year":"2024","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.neurot.2025.e00627_bib90","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fnins.2020.00267","article-title":"Nrf2 and ferroptosis: a new research direction for neurodegenerative diseases","volume":"14","author":"Song","year":"2020","journal-title":"Front Neurosci"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00627_bib91","doi-asserted-by":"crossref","DOI":"10.1186\/cc9257","article-title":"Effects of hydrogen sulfide on hemodynamics, inflammatory response and oxidative stress during resuscitated hemorrhagic shock in rats","volume":"14","author":"Ganster","year":"2010","journal-title":"Crit Care"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00627_bib92","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1021\/acschemneuro.5c00057","article-title":"Abd-elmawla MA. Interplay of endoplasmic reticulum stress, inflammation, apoptosis, and oxidative stress in corticosteroid-induced anxiety and depression: exploring therapeutic potential of hydrogen sulfide and sertraline","volume":"16","author":"Azzam","year":"2025","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.neurot.2025.e00627_bib93","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.niox.2024.09.006","article-title":"Hydrogen sulfide upregulates SIRT1 to inhibit ox-HDL-induced endothelial cell damage and mitochondrial dysfunction","volume":"152","author":"Zhao","year":"2024","journal-title":"Nitric Oxide"},{"issue":"14","key":"10.1016\/j.neurot.2025.e00627_bib94","article-title":"H(2)S-Releasing versatile montmorillonite nanoformulation trilogically renovates the gut microenvironment for inflammatory bowel disease modulation","volume":"11","author":"Jin","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00627_bib95","article-title":"Hydrogen sulfide interacting with cannabinoid 2 receptors during sciatic nerve injury-induced neuropathic pain","volume":"12","author":"Bai","year":"2023","journal-title":"Antioxidants (Basel)"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00627_bib96","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/jpp\/rgaa072","article-title":"Sodium hydrogen sulfide upregulates cystathionine beta-synthase and protects striatum against 3-nitropropionic acid-induced neurotoxicity in rats","volume":"73","author":"Mohammed","year":"2021","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00627_bib97","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pbb.2016.11.002","article-title":"Hydrogen sulfide ameliorates learning memory impairment in APP\/PS1 transgenic mice: a novel mechanism mediated by the activation of Nrf2","volume":"150\u2013151","author":"Liu","year":"2016","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neurot.2025.e00627_bib98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2014.01.004","article-title":"Hydrogen sulfide improves spatial memory impairment and decreases production of Abeta in APP\/PS1 transgenic mice","volume":"67","author":"He","year":"2014","journal-title":"Neurochem Int"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00627_bib99","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.pharep.2016.05.006","article-title":"Hydrogen sulfide down-regulates BACE1 and PS1 via activating PI3K\/Akt pathway in the brain of APP\/PS1 transgenic mouse","volume":"68","author":"He","year":"2016","journal-title":"Pharmacol Rep"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00627_bib100","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s12031-023-02134-x","article-title":"H(2)S alleviates neuropathic pain in mice by Nrf2 signaling pathway activation","volume":"73","author":"Wang","year":"2023","journal-title":"J Mol Neurosci"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00627_bib101","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/CIRCRESAHA.109.199919","article-title":"Hydrogen sulfide mediates cardioprotection through Nrf2 signaling","volume":"105","author":"Calvert","year":"2009","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00627_bib102","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/ALN.0b013e31823306cf","article-title":"Protective and detrimental effects of sodium sulfide and hydrogen sulfide in murine ventilator-induced lung injury","volume":"115","author":"Francis","year":"2011","journal-title":"Anesthesiology"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00627_bib103","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1089\/ars.2010.3821","article-title":"Hydrogen sulfide ameliorates tobacco smoke-induced oxidative stress and emphysema in mice","volume":"15","author":"Han","year":"2011","journal-title":"Antioxid Redox Signal"},{"issue":"15","key":"10.1016\/j.neurot.2025.e00627_bib104","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1089\/ars.2012.4645","article-title":"Hydrogen sulfide protects against cellular senescence via S-sulfhydration of Keap1 and activation of Nrf2","volume":"18","author":"Yang","year":"2013","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00627_bib105","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1089\/ars.2012.4944","article-title":"The gasotransmitter hydrogen sulfide induces nrf2-target genes by inactivating the keap1 ubiquitin ligase substrate adaptor through formation of a disulfide bond between cys-226 and cys-613","volume":"19","author":"Hourihan","year":"2013","journal-title":"Antioxid Redox Signal"},{"issue":"21","key":"10.1016\/j.neurot.2025.e00627_bib106","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1016\/j.febslet.2013.09.013","article-title":"Polysulfide exerts a protective effect against cytotoxicity caused by t-buthylhydroperoxide through Nrf2 signaling in neuroblastoma cells","volume":"587","author":"Koike","year":"2013","journal-title":"FEBS Lett"},{"key":"10.1016\/j.neurot.2025.e00627_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102965","article-title":"Thiosulfate sulfurtransferase deficiency promotes oxidative distress and aberrant NRF2 function in the brain","volume":"68","author":"Luo","year":"2023","journal-title":"Redox Biol"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00627_bib108","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1111\/j.1476-5381.2012.01949.x","article-title":"Platelet-derived growth factor-BB induces cystathionine gamma-lyase expression in rat mesangial cells via a redox-dependent mechanism","volume":"166","author":"Hassan","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00627_bib109","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.bbapap.2014.01.002","article-title":"H2S and its role in redox signaling","volume":"1844","author":"Kabil","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00627_bib110","doi-asserted-by":"crossref","DOI":"10.3390\/biom14091145","article-title":"Hydrogen sulfide: a versatile molecule and therapeutic target in health and diseases","volume":"14","author":"Shahid","year":"2024","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00627_bib111","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbadis.2016.11.005","article-title":"Nrf2 signaling pathway: pivotal roles in inflammation","volume":"1863","author":"Ahmed","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00627_bib112","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1080\/15548627.2016.1208889","article-title":"Transcription factor NFE2L2\/NRF2 is a regulator of macroautophagy genes","volume":"12","author":"Pajares","year":"2016","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00627_bib113","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/ars.2015.6549","article-title":"Repurposing the NRF2 activator dimethyl fumarate as therapy against synucleinopathy in Parkinson's disease","volume":"25","author":"Lastres-Becker","year":"2016","journal-title":"Antioxid Redox Signal"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00627_bib114","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1242\/bio.20134853","article-title":"Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration","volume":"2","author":"Holmstrom","year":"2013","journal-title":"Biol Open"},{"key":"10.1016\/j.neurot.2025.e00627_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101107","article-title":"NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis","volume":"23","author":"Dodson","year":"2019","journal-title":"Redox Biol"},{"key":"10.1016\/j.neurot.2025.e00627_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2024.102511","article-title":"Neuroprotective signaling by hydrogen sulfide and its dysregulation in Alzheimer's disease","volume":"82","author":"Paul","year":"2024","journal-title":"Curr Opin Chem Biol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00627_bib117","article-title":"Protective roles of hydrogen sulfide in alzheimer's disease and traumatic brain injury","volume":"12","author":"Paul","year":"2023","journal-title":"Antioxidants (Basel)"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00627_bib118","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1111\/bph.12806","article-title":"Pharmacological tools for hydrogen sulphide research: a brief, introductory guide for beginners","volume":"172","author":"Papapetropoulos","year":"2015","journal-title":"Br J Pharmacol"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00627_bib119","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1089\/ars.2021.0039","article-title":"Gasping for sulfide: a critical appraisal of hydrogen sulfide in lung disease and accelerated aging","volume":"35","author":"Pacitti","year":"2021","journal-title":"Antioxid Redox Signal"},{"issue":"18","key":"10.1016\/j.neurot.2025.e00627_bib120","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1161\/CIRCULATIONAHA.107.753467","article-title":"Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide","volume":"117","author":"Li","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.neurot.2025.e00627_bib121","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/bs.mie.2014.11.014","article-title":"GYY4137, a novel water-soluble, H2S-releasing molecule","volume":"554","author":"Rose","year":"2015","journal-title":"Methods Enzymol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00627_bib122","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1124\/pr.117.014050","article-title":"International union of basic and clinical pharmacology. CII: pharmacological modulation of H(2)S levels: H(2)S donors and H(2)S biosynthesis inhibitors","volume":"69","author":"Szabo","year":"2017","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.neurot.2025.e00627_bib123","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/978-3-319-18144-8_17","article-title":"Phosphinodithioate and phosphoramidodithioate hydrogen sulfide donors","volume":"230","author":"Whiteman","year":"2015","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00627_bib124","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3389\/fphar.2017.00741","article-title":"GYY4137, an H(2)S slow-releasing donor, prevents nitrative stress and alpha-synuclein nitration in an MPTP mouse model of Parkinson's disease","volume":"8","author":"Hou","year":"2017","journal-title":"Front Pharmacol"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00627_bib125","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23112966","article-title":"The H(2)S donor GYY4137 stimulates reactive oxygen species generation in BV2 cells while suppressing the secretion of TNF and nitric oxide","volume":"23","author":"Lazarevic","year":"2018","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00627_bib126","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12974-021-02085-3","article-title":"Microglia as target for anti-inflammatory approaches to prevent secondary brain injury after subarachnoid hemorrhage (SAH)","volume":"18","author":"Heinz","year":"2021","journal-title":"J Neuroinflammation"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00627_bib127","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s11064-023-03887-y","article-title":"Hydrogen sulphide-based therapeutics for neurological conditions: perspectives and challenges","volume":"48","author":"Sharif","year":"2023","journal-title":"Neurochem Res"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00627_bib128","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002368","article-title":"Sodium sulfide attenuates ischemic-induced heart failure by enhancing proteasomal function in an nrf2-dependent manner","volume":"9","author":"Shimizu","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00627_bib129","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/CIRCULATIONAHA.112.000855","article-title":"H(2)S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase","volume":"127","author":"Kondo","year":"2013","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00627_bib130","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/1755-5922.12128","article-title":"A novel hydrogen sulfide prodrug, SG1002, promotes hydrogen sulfide and nitric oxide bioavailability in heart failure patients","volume":"33","author":"Polhemus","year":"2015","journal-title":"Cardiovasc Ther"},{"issue":"14","key":"10.1016\/j.neurot.2025.e00627_bib131","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1089\/ars.2020.8060","article-title":"SG1002 and catenated divalent organic sulfur compounds as promising hydrogen sulfide prodrugs","volume":"33","author":"Gojon","year":"2020","journal-title":"Antioxid Redox Signal"},{"issue":"46","key":"10.1016\/j.neurot.2025.e00627_bib132","doi-asserted-by":"crossref","first-page":"17977","DOI":"10.1073\/pnas.0705710104","article-title":"Hydrogen sulfide mediates the vasoactivity of garlic","volume":"104","author":"Benavides","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"10.1016\/j.neurot.2025.e00627_bib133","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1021\/acs.orglett.5b01962","article-title":"Diallyl trisulfide is a fast H2S donor, but diallyl disulfide is a slow one: the reaction pathways and intermediates of glutathione with polysulfides","volume":"17","author":"Liang","year":"2015","journal-title":"Org Lett"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00627_bib134","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.molmed.2012.04.003","article-title":"Glucosinolates and isothiocyanates in health and disease","volume":"18","author":"Dinkova-Kostova","year":"2012","journal-title":"Trends Mol Med"},{"issue":"8-9","key":"10.1016\/j.neurot.2025.e00627_bib135","first-page":"610","article-title":"Hydrogen sulfide releasing capacity of natural isothiocyanates: is it a reliable explanation for the multiple biological effects of Brassicaceae?","volume":"80","author":"Citi","year":"2014","journal-title":"Planta Med"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00627_bib136","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.vph.2013.11.003","article-title":"Pharmacological characterization of the vascular effects of aryl isothiocyanates: is hydrogen sulfide the real player?","volume":"60","author":"Martelli","year":"2014","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00627_bib137","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.niox.2014.04.008","article-title":"AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro","volume":"41","author":"Szczesny","year":"2014","journal-title":"Nitric Oxide"},{"issue":"Pt A","key":"10.1016\/j.neurot.2025.e00627_bib138","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.phrs.2016.08.019","article-title":"The novel mitochondria-targeted hydrogen sulfide (H(2)S) donors AP123 and AP39 protect against hyperglycemic injury in microvascular endothelial cells in vitro","volume":"113","author":"Gero","year":"2016","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00627_bib139","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/SHK.0000000000000478","article-title":"AP39, A mitochondrially targeted hydrogen sulfide donor, exerts protective effects in renal epithelial cells subjected to oxidative stress in vitro and in acute renal injury in vivo","volume":"45","author":"Ahmad","year":"2016","journal-title":"Shock"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00627_bib140","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1377\/hlthaff.4.2.60","article-title":"Innovations in medical curricula: templates for change?","volume":"4","author":"Siu","year":"1985","journal-title":"Health Aff"},{"key":"10.1016\/j.neurot.2025.e00627_bib141","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.2147\/DDDT.S507697","article-title":"Novel AP39-loaded liposomes sustain the release of hydrogen sulphide, enhance blood-brain barrier permeation, and abrogate oxidative stress-induced mitochondrial dysfunction in brain cells","volume":"19","author":"Al Tahan","year":"2025","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.neurot.2025.e00627_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtemb.2025.127628","article-title":"Multidimensional analysis of selected bioelements in rat's brain subjected to stroke procedure and treatment with H(2)S donor AP-39","volume":"88","author":"Rospond","year":"2025","journal-title":"J Trace Elem Med Biol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00627_bib143","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1021\/acsbiomaterials.4c02282","article-title":"Intranasal administrations of AP39-loaded liposomes selectively deliver H2S to neuronal mitochondria to protect neonatal hypoxia-ischemia by targeting ERK1\/2 and caspase-1","volume":"11","author":"Song","year":"2025","journal-title":"ACS Biomater Sci Eng"},{"key":"10.1016\/j.neurot.2025.e00627_bib144","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neuroscience.2023.11.008","article-title":"The hydrogen sulfide donor AP39 reduces glutamate-mediated excitotoxicity in a rat model of brain ischemia","volume":"539","author":"Skorkowska","year":"2024","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00627_bib145","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1476-5381.2009.00611.x","article-title":"Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346)","volume":"159","author":"Wallace","year":"2010","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00627_bib146","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/bph.14641","article-title":"A proof-of-concept, Phase 2 clinical trial of the gastrointestinal safety of a hydrogen sulfide-releasing anti-inflammatory drug","volume":"177","author":"Wallace","year":"2020","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00627_bib147","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00005344-198906000-00011","article-title":"Preclinical pharmacology of zofenopril, an inhibitor of angiotensin I converting enzyme","volume":"13","author":"DeForrest","year":"1989","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00627_bib148","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/cvr\/cvu026","article-title":"Hydrogen sulfide accounts for the peripheral vascular effects of zofenopril independently of ACE inhibition","volume":"102","author":"Bucci","year":"2014","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00627_bib149","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00129784-200707010-00002","article-title":"Defining the role of zofenopril in the management of hypertension and ischemic heart disorders","volume":"7","author":"Ambrosioni","year":"2007","journal-title":"Am J Cardiovasc Drugs"},{"issue":"23","key":"10.1016\/j.neurot.2025.e00627_bib150","doi-asserted-by":"crossref","first-page":"17318","DOI":"10.1074\/jbc.M110.115261","article-title":"Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: potential for treating Parkinson disease","volume":"285","author":"Lee","year":"2010","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00627_bib151","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060200","article-title":"Therapeutic effect of hydrogen sulfide-releasing L-Dopa derivative ACS84 on 6-OHDA-induced Parkinson's disease rat model","volume":"8","author":"Xie","year":"2013","journal-title":"PLoS One"},{"issue":"38","key":"10.1016\/j.neurot.2025.e00627_bib152","doi-asserted-by":"crossref","first-page":"32124","DOI":"10.1074\/jbc.M112.374124","article-title":"A novel hydrogen sulfide-releasing N-methyl-D-aspartate receptor antagonist prevents ischemic neuronal death","volume":"287","author":"Marutani","year":"2012","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00627_bib153","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1038\/s41598-019-40925-8","article-title":"Memantine prodrug as a new agent for Alzheimer's Disease","volume":"9","author":"Sestito","year":"2019","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00627_bib154","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/glia.22553","article-title":"NOSH-aspirin (NBS-1120), a novel nitric oxide and hydrogen sulfide releasing hybrid, attenuates neuroinflammation induced by microglial and astrocytic activation: a new candidate for treatment of neurodegenerative disorders","volume":"61","author":"Lee","year":"2013","journal-title":"Glia"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00627_bib155","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00018-022-04479-9","article-title":"H(2)S biogenesis by cystathionine beta-synthase: mechanism of inhibition by aminooxyacetic acid and unexpected role of serine","volume":"79","author":"Petrosino","year":"2022","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00627_bib156","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1074\/jbc.M115.681221","article-title":"S-Adenosyl-l-methionine modulates CO and NO\u2217 binding to the human H2S-generating enzyme cystathionine beta-synthase","volume":"291","author":"Vicente","year":"2016","journal-title":"J Biol Chem"},{"issue":"21","key":"10.1016\/j.neurot.2025.e00627_bib157","doi-asserted-by":"crossref","first-page":"21290","DOI":"10.18632\/aging.103863","article-title":"S-adenosylmethionine administration inhibits levodopa-induced vascular endothelial growth factor-A expression","volume":"12","author":"Yan","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00627_bib158","doi-asserted-by":"crossref","first-page":"758","DOI":"10.2119\/molmed.2015.00221","article-title":"Overexpression of cystathionine gamma-lyase suppresses detrimental effects of spinocerebellar ataxia type 3","volume":"21","author":"Snijder","year":"2016","journal-title":"Mol Med"},{"issue":"1-2","key":"10.1016\/j.neurot.2025.e00627_bib159","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000494113","article-title":"Mechanisms of hydrogen sulfide against the progression of severe Alzheimer's disease in transgenic mice at different ages","volume":"103","author":"Vandini","year":"2019","journal-title":"Pharmacology"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00627_bib160","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.neuron.2019.02.017","article-title":"Therapeutic AAV gene transfer to the nervous system: a clinical reality","volume":"101","author":"Hudry","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.neurot.2025.e00627_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115363","article-title":"Adeno-associated virus vector delivery to the brain: technology advancements and clinical applications","volume":"211","author":"Ye","year":"2024","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00627_bib162","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.chembiol.2018.04.001","article-title":"S marks the spot: linking the antioxidant activity of N-acetyl cysteine to H(2)S and sulfane sulfur species","volume":"25","author":"Cerda","year":"2018","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.neurot.2025.e00627_bib163","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bcp.2017.11.014","article-title":"A review of hydrogen sulfide (H(2)S) donors: chemistry and potential therapeutic applications","volume":"149","author":"Powell","year":"2018","journal-title":"Biochem Pharmacol"},{"issue":"20","key":"10.1016\/j.neurot.2025.e00627_bib164","article-title":"Neurotrophic factor BDNF, physiological functions and therapeutic potential in depression, neurodegeneration and brain cancer","volume":"21","author":"Colucci-D'Amato","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2025.e00627_bib165","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fncel.2019.00363","article-title":"Brain-derived neurotrophic factor: a key molecule for memory in the healthy and the pathological brain","volume":"13","author":"Miranda","year":"2019","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00627_bib166","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/2045-9912.350863","article-title":"Therapeutic applications of hydrogen sulfide and novel donors for cerebral ischemic stroke: a narrative review","volume":"13","author":"Ding","year":"2023","journal-title":"Med Gas Res"},{"issue":"23","key":"10.1016\/j.neurot.2025.e00627_bib167","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.1523\/JNEUROSCI.0426-16.2016","article-title":"Distinct Nrf2 signaling mechanisms of fumaric acid esters and their role in neuroprotection against 1-methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-induced experimental Parkinson's-like disease","volume":"36","author":"Ahuja","year":"2016","journal-title":"J Neurosci"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00627_bib168","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrd4433","article-title":"Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter","volume":"14","author":"Wallace","year":"2015","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00627_bib169","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1007\/s00204-018-2208-x","article-title":"Activation of autophagic flux and the Nrf2\/ARE signaling pathway by hydrogen sulfide protects against acrylonitrile-induced neurotoxicity in primary rat astrocytes","volume":"92","author":"Yang","year":"2018","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.neurot.2025.e00627_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103066","article-title":"Hydrogen sulfide protects cardiomyocytes from doxorubicin-induced ferroptosis through the SLC7A11\/GSH\/GPx4 pathway by Keap1 S-sulfhydration and Nrf2 activation","volume":"70","author":"Zhang","year":"2024","journal-title":"Redox Biol"},{"issue":"177","key":"10.1016\/j.neurot.2025.e00627_bib171","doi-asserted-by":"crossref","first-page":"576","DOI":"10.24976\/Discov.Med.202335177.58","article-title":"H(2)S alleviates propofol-induced impaired learning and memory by promoting nuclear translocation of Nrf2 and inhibiting apoptosis and pyroptosis in hippocampal neurons","volume":"35","author":"Li","year":"2023","journal-title":"Discov Med"},{"key":"10.1016\/j.neurot.2025.e00627_bib172","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.844539","article-title":"H(2)S protects against immobilization-induced muscle atrophy via reducing oxidative stress and inflammation","volume":"13","author":"Xu","year":"2022","journal-title":"Front Physiol"},{"key":"10.1016\/j.neurot.2025.e00627_bib173","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.68487","article-title":"Hydrogen sulfide blocks HIV rebound by maintaining mitochondrial bioenergetics and redox homeostasis","volume":"10","author":"Pal","year":"2021","journal-title":"eLife"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00627_bib174","article-title":"Hydrogen sulfide inhibits inflammatory pain and enhances the analgesic properties of delta opioid receptors","volume":"10","author":"Porta","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.neurot.2025.e00627_bib175","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.freeradbiomed.2024.10.292","article-title":"Mesenchymal stromal cells deliver H(2)S-enhanced Nrf2 via extracellular vesicles to mediate mitochondrial homeostasis for repairing hypoxia-ischemia brain damage","volume":"225","author":"Gai","year":"2024","journal-title":"Free Radic Biol Med"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925001059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925001059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:34:21Z","timestamp":1763638461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747925001059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":175,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1878747925001059"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00627","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intersection of H2S and Nrf2 signaling: Therapeutic opportunities for neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00627","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00627"}}